(Q43036702)

English

Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia

scientific article published on 10 June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

0 references

Attila Molvarec

object named as

Attila Molvarec

1

0 references

author name string

András Szarka

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Szilvia Walentin

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Endre Szucs

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Bálint Nagy

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

János Rigó

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

10 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hypertension Research

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

892-898

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

https://scigraph.springernature.com/pub.10.1038/hr.2010.92

0 references

Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Preeclampsia: an endothelial cell disorder

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Toll-like receptor 4 gene polymorphisms and preeclampsia: lack of association in a Caucasian population.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Methylenetetrahydrofolate reductase C677T and glutathione S-transferase P1 A313G are associated with a reduced risk of preeclampsia in Maya-Mestizo women.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

The M235T variant of the angiotensinogen gene is related to development of self-reported hypertension during pregnancy: the Prospect-EPIC cohort study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Cytokine gene polymorphisms in preeclampsia and eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Preeclampsia is associated with decreased serum alpha(2)-HS glycoprotein (fetuin-A) concentration

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Circulating anti-heat-shock-protein antibodies in normal pregnancy and preeclampsia.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Roles for VEGF in the adult.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Circulating angiogenic factors and the risk of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Glomerular endothelial cells are maintained by vascular endothelial growth factor in the adult kidney.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Establishing Reference Values for Both Total Soluble Fms-Like Tyrosine Kinase 1 and Free Placental Growth Factor in Pregnant Women

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

THE LEVELS OF CIRCULATORY FETAL DNA IN MATERNAL PLASMA ARE ELEVATED PRIOR TO THE ONSET OF PREECLAMPSIA

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Preeclampsia: recent insights

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Vascular endothelial growth factor and placental growth factor release in cultured trophoblast cells under different oxygen tensions.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Expression and function of placenta growth factor: implications for abnormal placentation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Toll-like receptor-3 stimulation upregulates sFLT-1 production by trophoblast cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

21 January 2018

Normal and high-normal blood pressures, but not body mass index, are risk factors for the subsequent occurrence of both preeclampsia and gestational hypertension: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Leptin gene (TTTC)(n) microsatellite polymorphism in pre-eclampsia and HELLP syndrome

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case-control study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum heat shock protein 70 levels are decreased in normal human pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Presence of cell-free fetal DNA in plasma of women with ectopic pregnancies

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Clotting inhibitors and fibronectin as potential markers in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

A Vascular Endothelial Growth Factor Antagonist Is Produced by the Human Placenta and Released into the Maternal Circulation1

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Trophoblast deportation in human pregnancy--its relevance for pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma markers of angiogenesis in pregnancy induced hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating leptin and angiogenic factors in preeclampsia patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/HR.2010.92

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43036702&oldid=1978280417"